Ferroptosis in liver disease: new insights into disease mechanisms
Autor: | Yi Wang, Xuehong Yin, Rongtao Jiang, Muchen Wu, Jing Wu, Ran Xue, Qing-Hua Meng |
---|---|
Rok vydání: | 2021 |
Předmět: |
Liver injury
Cancer Research Programmed cell death Alcoholic liver disease QH573-671 Hepatocellular carcinoma business.industry Immunology Neoplasms. Tumors. Oncology. Including cancer and carcinogens Review Article Cell Biology Mitochondrion medicine.disease GPX4 Cellular and Molecular Neuroscience Liver disease Nonalcoholic fatty liver disease medicine Cancer research Cytology business RC254-282 Liver diseases Hemochromatosis |
Zdroj: | Cell Death Discovery Cell Death Discovery, Vol 7, Iss 1, Pp 1-9 (2021) |
ISSN: | 2058-7716 |
DOI: | 10.1038/s41420-021-00660-4 |
Popis: | Characterized by excessive iron accumulation and lipid peroxidation, ferroptosis is a novel form of iron-dependent cell death, which is morphologically, genetically, and biochemically distinct from other well-known cell death. In recent years, ferroptosis has been quickly gaining attention in the field of liver diseases, as the liver is predisposed to oxidative injury and generally, excessive iron accumulation is a primary characteristic of most major liver diseases. In the current review, we first delineate three cellular defense mechanisms against ferroptosis (GPx4 in the mitochondria and cytosol, FSP1 on plasma membrane, and DHODH in mitochondria), along with four canonical modulators of ferroptosis (system Xc−, nuclear factor erythroid 2-related factor 2, p53, and GTP cyclohydrolase-1). Next, we review recent progress of ferroptosis studies delineating molecular mechanisms underlying the pathophysiology of several common liver diseases including ischemia/reperfusion-related injury (IRI), nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), hemochromatosis (HH), drug-induced liver injury (DILI), and hepatocellular carcinoma (HCC). Furthermore, we also highlight both challenges and promises that emerged from recent studies that should be addressed and pursued in future investigations before ferroptosis regulation could be adopted as an effective therapeutic target in clinical practice. |
Databáze: | OpenAIRE |
Externí odkaz: |